Fundraising Fox

Greyledge Technologies

Lone Tree, US · Founded 2020 · Nevada corporation

Greyledge Technologies is a clinical biotech company working on autologous cell therapeutics, including Platelet Rich Plasma (PRP) and Bone Marrow Concentrate (BMC). It quantifies and controls cell populations within its products to research and customize treatments for specific patients and clinical applications.

Founders & leadership

DKDavid Karli
David KarliChief Executive Officer
ZB
Zoe Bedford KarliPresident

Reported raises · per SEC filings

Form D private placements

$4.3M disclosed across 1 round · 2022

$4.3MraisedMay 2023 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David KarliExecutive Officer, Director
  • Zoe Bedford KarliExecutive Officer, Director
Offering amount
$4.3M
Amount sold
$4.3M
First sale
Mar 2022
Incorporated
Corporation, Nevada, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Companies competing with Greyledge Technologies for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Greyledge Technologies do?
Greyledge Technologies is a clinical biotech company working on autologous cell therapeutics, including Platelet Rich Plasma (PRP) and Bone Marrow Concentrate (BMC). It quantifies and controls cell populations within its products to research and customize treatments for specific patients and clinical applications.
How much funding has Greyledge Technologies raised?
Greyledge Technologies has disclosed $4.3M raised across 1 round.
Where is Greyledge Technologies headquartered?
Greyledge Technologies is headquartered in Lone Tree, US.